News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
KANIA EDWIN M JR
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/30/2023 |
4
| KANIA EDWIN M JR (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 1,193 shares
@ $0
Granted 1,916 options to buy
@ $71.33, valued at
$136.7k
|
|
| 03/02/2023 |
4
| KANIA EDWIN M JR (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Acquired 145,601 shares
@ $79.76, valued at
$11.6M
Acquired 96,876 shares
@ $79.76, valued at
$7.7M
|
|
| 06/06/2022 |
4
| KANIA EDWIN M JR (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Granted 13,500 options to buy
@ $28.12, valued at
$379.6k
|
|
| 11/30/2021 |
4
| KANIA EDWIN M JR (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Bought 25,938 shares
@ $22.14, valued at
$574.3k
Bought 74,062 shares
@ $22.71, valued at
$1.7M
|
|
| 11/22/2021 |
4
| KANIA EDWIN M JR (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Disposed of 779,571 shares
@ $0
Disposed of 25,234 shares
@ $0
Disposed of 3,873 shares
@ $0
Gifted 11,000 shares
@ $0
Disposed of 46,142 shares
@ $0
Acquired 48,966 shares
@ $0 |
|
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2020 |
4
| KANIA EDWIN M JR (10% Owner) has filed a Form 4 on Moderna, Inc.|
Txns:
| Sold 357,375 shares
@ $20.3427, valued at
$7.3M
Sold 117,625 shares
@ $20.0114, valued at
$2.4M
|
|
| 12/12/2019 |
4
| KANIA EDWIN M JR (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Disposed of 390,000 shares
@ $0
Acquired 3,873 shares
@ $0 |
|
| 12/11/2019 |
4
| KANIA EDWIN M JR (10% Owner) has filed a Form 4 on Moderna, Inc.|
Txns:
| Sold 100,000 shares
@ $18.8084, valued at
$1.9M
|
|
| 12/11/2019 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Moderna, Inc.|
Txns:
| Disposed of 6,292,342 shares
@ $0
Disposed of 1,207,658 shares
@ $0
Disposed of 1,735,720 shares
@ $0
Sold 144,423 shares
@ $18.9942, valued at
$2.7M
Sold 27,714 shares
@ $18.9943, valued at
$526.4k
Sold 21,325 shares
@ $18.9586, valued at
$404.3k
Sold 4,092 shares
@ $18.9586, valued at
$77.6k
Sold 199,935 shares
@ $18.6548, valued at
$3.7M
Sold 38,366 shares
@ $18.6548, valued at
$715.7k
|
|
| 10/31/2019 |
4
| KANIA EDWIN M JR (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Acquired 92,796 shares
@ $0
Acquired 27,799 shares
@ $0 |
|
| 05/15/2019 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Converted 751,691 shares
@ $0
Converted 2,255,074 shares
@ $0
Converted 209,933 shares
@ $0
Converted 503,840 shares
@ $0
Converted 545,826 shares
@ $0
Converted 120,795 shares
@ $0
Converted 335,457 shares
@ $0
Converted 82,324 shares
@ $0
Converted 194,409 shares
@ $0
Converted 48,602 shares
@ $0
Converted 486,023 shares
@ $0 |
|
| 05/08/2019 |
3
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 3 on Axcella Health Inc. |
| 05/06/2019 |
4
| KANIA EDWIN M JR (Director) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Disposed of 1,271,619 shares
@ $0
Acquired 363,320 shares
@ $0
Disposed of 26,288 shares
@ $0
Acquired 7,511 shares
@ $0
Converted 806,252 shares
@ $0
Converted 17,724 shares
@ $0
Converted 57,142 shares
@ $0
Bought 33,333 shares
@ $16, valued at
$533.3k
Converted 10,756 convertible preferred
@ $0
Converted 791,501 convertible preferred
@ $0
Converted 1,119,394 convertible preferred
@ $0 |
|
| 05/01/2019 |
3
| KANIA EDWIN M JR (Director) has filed a Form 3 on TransMedics Group, Inc. |
| 03/06/2019 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Converted 665,908 shares
@ $0
Converted 173,586 shares
@ $0
Converted 281,203 shares
@ $0
Converted 1,331,816 preferred shares
@ $0
Converted 347,173 preferred shares
@ $0
Converted 562,407 preferred shares
@ $0 |
|
| 02/27/2019 |
3
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 3 on Kaleido Biosciences, Inc. |
| 12/13/2018 |
4
| AFEYAN NOUBAR (10% Owner) has filed a Form 4 on Moderna, Inc.|
Txns:
| Converted 7,292,145 shares
@ $0
Converted 1,823,036 shares
@ $0
Converted 24,782,551 shares
@ $0
Converted 6,195,632 shares
@ $0
Converted 5,713,739 shares
@ $0
Converted 1,428,432 shares
@ $0
Converted 85,989 shares
@ $0
Converted 21,496 shares
@ $0
Converted 7,292,145 preferred shares
@ $0
Converted 1,823,036 preferred shares
@ $0
Converted 24,782,551 preferred shares
@ $0 |
|
| 12/07/2018 |
3
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 3 on Moderna, Inc. |
| 07/23/2018 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Converted 15,323,593 shares
@ $0
Converted 3,830,402 shares
@ $0
Converted 5,000,000 shares
@ $0
Converted 5,000,000 shares
@ $0
Converted 593,948 shares
@ $0
Converted 593,948 shares
@ $0
Converted 1,781,843 shares
@ $0
Converted 195,466 shares
@ $0
Converted 195,466 shares
@ $0
Converted 781,860 shares
@ $0
Converted 15,323,593 preferred shares
@ $0 |
|
| 07/17/2018 |
3
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 3 on Rubius Therapeutics, Inc. |
| 05/15/2018 |
4
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Converted 14,622,143 shares
@ $0
Bought 281,250 shares
@ $16, valued at
$4.5M
Converted 12,536,945 preferred shares
@ $0
Converted 10,102,055 preferred shares
@ $0
Converted 5,416,667 preferred shares
@ $0
Converted 8,333,000 options to buy
@ $0
Converted 18,611,110 preferred shares
@ $0
Converted 4,643,963 preferred shares
@ $0 |
|
| 05/08/2018 |
3
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 3 on Evelo Biosciences, Inc. |
| 12/13/2017 |
4
| Flagship Ventures Fund 2004 L P (10% Owner) has filed a Form 4 on Quanterix Corp|
Txns:
| Converted 398,257 shares
@ $0
Converted 1,045,426 shares
@ $0
Converted 477,042 shares
@ $0
Converted 109,770 shares
@ $0
Converted 1,280,000 preferred shares
@ $0
Converted 3,360,000 preferred shares
@ $0
Converted 1,533,214 preferred shares
@ $0
Converted 352,800 preferred shares
@ $0 |
|
| 12/06/2017 |
3
| Flagship Ventures Fund 2004 L P (10% Owner) has filed a Form 3 on Quanterix Corp |
| 08/21/2017 |
4
| Flagship Ventures Fund IV, L.P. (10% Owner) has filed a Form 4 on Syros Pharmaceuticals, Inc.|
Txns:
| Disposed of 1,295,997 shares
@ $0
Disposed of 306,222 shares
@ $0
Disposed of 54,293 shares
@ $0 |
|
| 05/16/2017 |
4
| KANIA EDWIN M JR (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC |
| 09/26/2016 |
4
| Flagship Ventures Fund IV, L.P. (10% Owner) has filed a Form 4 on Eleven Biotherapeutics, Inc. |
| 09/21/2016 |
4
| Flagship Ventures Fund IV, L.P. (10% Owner) has filed a Form 4 on Eleven Biotherapeutics, Inc. |
| 09/16/2016 |
4
| Flagship Ventures Fund IV, L.P. (10% Owner) has filed a Form 4 on Eleven Biotherapeutics, Inc. |
| 09/08/2016 |
4
| Flagship Ventures Fund IV, L.P. (10% Owner) has filed a Form 4 on Eleven Biotherapeutics, Inc. |
| 08/15/2016 |
4
| Flagship Ventures Fund IV, L.P. (10% Owner) has filed a Form 4 on Editas Medicine, Inc. |
| 07/07/2016 |
4
| Flagship Ventures Fund IV, L.P. (10% Owner) has filed a Form 4 on Syros Pharmaceuticals, Inc. |
| 06/29/2016 |
3
| Flagship Ventures Fund IV, L.P. (10% Owner) has filed a Form 3 on Syros Pharmaceuticals, Inc. |
|
|
|